Literature DB >> 24136591

Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain.

Maria Luisa Mateos-Lindemann1, María Diez-Aguilar, Ana L Gonzalez Galdamez, Juan Carlos Galán, Ana Moreno, María Teresa Pérez-Gracia.   

Abstract

Hepatitis E virus is responsible for sporadic cases of acute, self-limited viral hepatitis not only in endemic but also in industrialized countries. In addition, some reports confirm that it can cause chronic infection and even cirrhosis in immunosuppressed and also in patients infected with HIV. There are few data about prevalence and incidence of HEV chronic infection in HIV-HEV coinfected individuals in Spain. The aim of this study is to investigate the prevalence of anti-HEV IgG in a representative sample of 448 patients infected with HIV and determine the role of age, gender, and CD4 counts in the detection of anti-HEV IgG antibodies in blood. In addition, the clinical features and ALT levels in relation to the presence of anti-HEV IgM and/or HEV-RNA in the blood of these patients were investigated. Anti-HEV IgG antibodies were detected in serum using a commercial enzyme immunoassay. All positive samples were studied further for the presence of anti-HEV IgM antibodies. In addition, HEV RNA was amplified by reverse transcriptase (RT)-nested PCR in all serum samples with IgM anti-HEV. The overall prevalence of anti-HEV IgG was 10.4% (45/448, 95% C.I. 7.2-12.8%). HEV-RNA was found in only one patient out of the 45 anti-HEV IgG positive samples studied. Regarding to gender and CD4 count, no difference in seroprevalence could be observed. This prevalence data suggest that patients infected with HIV can be considered a risk group for HEV infection and that chronic coinfection HEV-HIV seems to be a very rare event.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  HIV-HEV coinfection; HIV-infected patients; hepatitis E

Mesh:

Substances:

Year:  2013        PMID: 24136591     DOI: 10.1002/jmv.23804

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Current Knowledge on Hepatitis E.

Authors:  María Teresa Pérez-Gracia; Mario García; Beatriz Suay; María Luisa Mateos-Lindemann
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

2.  Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy.

Authors:  Simone Lanini; Anna Rosa Garbuglia; Daniele Lapa; Vincenzo Puro; Assunta Navarra; Catia Pergola; Giuseppe Ippolito; Maria Rosaria Capobianchi
Journal:  BMJ Open       Date:  2015-07-14       Impact factor: 2.692

3.  Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran.

Authors:  Hassan Joulaei; Omid Rudgari; Nasrin Motazedian; Samaneh Gorji-Makhsous
Journal:  Iran J Microbiol       Date:  2015-04

4.  Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection.

Authors:  Mar Riveiro-Barciela; María Buti; María Homs; Isabel Campos-Varela; Carmen Cantarell; Manuel Crespo; Lluís Castells; David Tabernero; Josep Quer; Rafael Esteban; Francisco Rodriguez-Frías
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

Review 5.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

Review 6.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

7.  Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014).

Authors:  Sonia Vázquez-Morón; Juan Berenguer; Juan González-García; Ma Ángeles Jiménez-Sousa; Isabel Canorea; Josep M Guardiola; Manuel Crespo; Carmen Quereda; José Sanz; Ana Carrero; Victor Hontañón; Ana Avellón; Salvador Resino
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.